I am a
Home I AM A Search Login

2022 Mar 11

Gastroenterol Hepatol


Sharkawi F Z E, El-Sherbiny M, Ali S A-E-M, Nassif WMH
Gastroenterol Hepatol. 2022 Mar 11.
PMID: 35288234.


There is an obvious need to diagnose hepatocellular carcinoma using novel non-invasive and sensitive biomarkers. Circular RNAs have recently attracted great interest as promising biomarkers and treatment targets. However, their function in hepatocellular carcinoma whose etiology related to hepatitis C has been rarely studied. Aim of work; the current study was conducted to analyze differential expression of circ-ITCH in plasma of Egyptian HCC patients with concomitant HCV infection, compared to normal control subjects, to investigate its correlation with liver function parameters, and to determine the possible diagnostic ability of circ-ITCH in plasma as a non-invasive marker, compared to its linear counterpart. Results; The results showed that the relative expression of circ-ITCH was significantly higher in the plasma of HCC patients (P <0.05). Moreover, when comparing its expression in the metastatic and non-metastatic subgroups, it was significantly higher in the non-metastatic HCC group compared to control group (P <0.05). Circ-ITCH was positively correlated with liver enzymes AST, ALT (p <0.001), also was significantly higher in HCC child C patients. To evaluate the potential diagnostic value of circ-ITCH in plasma, a ROC curve was generated, the AUC was 0.661, (95% CI: 0.5433 – 0.778) with a sensitivity and specificity 65 % and 70% respectively. Conclusion; The results revealed that circ-ITCH is-with no doubt-involved in the pathogenesis of HCC and its high level may be related to HCV infection, further researches in this area will certainly make great contributions in understanding. In conclusion our results suggested that circ-ITCH may be used as a noninvasive diagnostic marker and a promising therapeutic target for HCC.